106 related articles for article (PubMed ID: 2697435)
1. Failure to immortalise human AML cells using human recombinant GMCSF in vitro and in vivo.
Clutterbuck R; Newman A; Powles R; Kwong Y; Millar J; Shepherd V; Smith C
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():40-1. PubMed ID: 2697435
[TBL] [Abstract][Full Text] [Related]
2. Clinical role of granulocyte-macrophage colony-stimulating factor.
Mitsuyasu RT; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
[TBL] [Abstract][Full Text] [Related]
3. GM-CSF in combination with cytotoxic chemotherapy in AML patients.
Bettelheim P; Muhm M; Valent P; Geissler K; Andreeff M; Haimi J; Sillaber C; Hinterberger W; Vieder L; Schulz G
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():127-30. PubMed ID: 2202464
[No Abstract] [Full Text] [Related]
4. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
5. [GM-CSF: its clinical administration; the treatment of aplasia].
Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
[No Abstract] [Full Text] [Related]
6. [GM-CSF: its use in onco-hematologic diseases].
Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
[No Abstract] [Full Text] [Related]
7. Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) treatment of patients with acute leukemias in aplasia and at high risk of early death.
Büchner T; Hiddemann W; Zühlsdorf M; Koenigsmann M; Böckmann A; van de Loo J; Schulz G
Behring Inst Mitt; 1988 Aug; (83):309-12. PubMed ID: 3071345
[TBL] [Abstract][Full Text] [Related]
8. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation.
Blazar BR; Widmer MB; Kersey JH; Ramsay NK; McGlave PB; Urdal DL; Gillis S; Henney C; Vallera DA
Behring Inst Mitt; 1988 Aug; (83):170-80. PubMed ID: 3071335
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.
Nienhuis AW; Donahue RE; Karlsson S; Clark SC; Agricola B; Antinoff N; Pierce JE; Turner P; Anderson WF; Nathan DG
J Clin Invest; 1987 Aug; 80(2):573-7. PubMed ID: 3301903
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.
Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K
Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642
[No Abstract] [Full Text] [Related]
11. Acceleration of autologous hematopoietic recovery by GM-CSF after allograft rejection.
Bandini G; Rosti G; Cavo M; Albertazzi L; Tura S
Haematologica; 1989; 74(6):627-8. PubMed ID: 2697676
[No Abstract] [Full Text] [Related]
12. Effects of transforming growth factor beta 1 on growth and apoptosis of human acute myelogenous leukemia cells.
Taetle R; Payne C; Dos Santos B; Russell M; Segarini P
Cancer Res; 1993 Jul; 53(14):3386-93. PubMed ID: 8324749
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.
Emerson SG; Yang YC; Clark SC; Long MW
J Clin Invest; 1988 Oct; 82(4):1282-7. PubMed ID: 3049674
[TBL] [Abstract][Full Text] [Related]
14. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
[TBL] [Abstract][Full Text] [Related]
15. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
16. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
17. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC
Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
Champlin RE; Nimer SD; Oette D; Golde DW
Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
[No Abstract] [Full Text] [Related]
19. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T
Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
Gajewski TF; Goldwasser E; Fitch FW
J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
